<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1399" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1399/" /><meta name="ncbi_pagename" content="Spinocerebellar Ataxia Type 14 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Spinocerebellar Ataxia Type 14 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Spinocerebellar Ataxia Type 14" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/04/18" /><meta name="citation_author" content="Dong-Hui Chen" /><meta name="citation_author" content="Thomas D Bird" /><meta name="citation_author" content="Wendy H Raskind" /><meta name="citation_pmid" content="20301573" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1399/" /><meta name="citation_keywords" content="SCA14" /><meta name="citation_keywords" content="SCA14" /><meta name="citation_keywords" content="SCA 14" /><meta name="citation_keywords" content="Protein kinase C gamma type" /><meta name="citation_keywords" content="PRKCG" /><meta name="citation_keywords" content="Spinocerebellar Ataxia Type 14" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Spinocerebellar Ataxia Type 14" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Dong-Hui Chen" /><meta name="DC.Contributor" content="Thomas D Bird" /><meta name="DC.Contributor" content="Wendy H Raskind" /><meta name="DC.Date" content="2013/04/18" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1399/" /><meta name="description" content="Spinocerebellar ataxia type 14 (SCA14) is characterized by slowly progressive cerebellar ataxia, dysarthria, and nystagmus. Axial myoclonus, cognitive impairment, tremor, and sensory loss may also be observed. Parkinsonian features including rigidity and tremor have been described in some families. Findings seen in other ataxia disorders (e.g., dysphagia, dysphonia) may also occur in SCA14. Age of onset ranges from childhood to the sixth decade. Life span is not shortened." /><meta name="og:title" content="Spinocerebellar Ataxia Type 14" /><meta name="og:type" content="book" /><meta name="og:description" content="Spinocerebellar ataxia type 14 (SCA14) is characterized by slowly progressive cerebellar ataxia, dysarthria, and nystagmus. Axial myoclonus, cognitive impairment, tremor, and sensory loss may also be observed. Parkinsonian features including rigidity and tremor have been described in some families. Findings seen in other ataxia disorders (e.g., dysphagia, dysphonia) may also occur in SCA14. Age of onset ranges from childhood to the sixth decade. Life span is not shortened." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1399/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sca14/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1399/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8DDCBAE041F6510000000004BF01C4.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1399_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1399_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca13/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca15/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1399_"><span class="title" itemprop="name">Spinocerebellar Ataxia Type 14</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: SCA14</div><p class="contrib-group"><span itemprop="author">Dong-Hui Chen</span>, MD, PhD, <span itemprop="author">Thomas D Bird</span>, MD, and <span itemprop="author">Wendy H Raskind</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1399_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1399_ai__"><div class="contrib half_rhythm"><span itemprop="author">Dong-Hui Chen</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />University of Washington Medical Center<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@iuhdc" class="oemail">ude.wu@iuhdc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Thomas D Bird</span>, MD<div class="affiliation small">Departments of Neurology and Medicine<br />University of Washington<br />Seattle VA Medical Center<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@zornmot" class="oemail">ude.wu@zornmot</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Wendy H Raskind</span>, MD, PhD<div class="affiliation small">Professor, Departments of Medicine and Psychiatry and Behavioral Sciences<br />University of Washington Medical Center<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@nurydnew" class="oemail">ude.wu@nurydnew</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 28, 2005</span>; Last Update: <span itemprop="dateModified">April 18, 2013</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sca14.Summary" itemprop="description"><h2 id="_sca14_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Spinocerebellar ataxia type 14 (SCA14) is characterized by slowly progressive cerebellar ataxia, dysarthria, and nystagmus. Axial myoclonus, cognitive impairment, tremor, and sensory loss may also be observed. Parkinsonian features including rigidity and tremor have been described in some families. Findings seen in other ataxia disorders (e.g., dysphagia, dysphonia) may also occur in SCA14. Age of onset ranges from childhood to the sixth decade. Life span is not shortened.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SCA14 relies on the use of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRKCG</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Clonazepam or valproic acid to help improve axial myoclonus; canes and walkers to help prevent falls; modification of the home (grab bars, raised toilet seats, ramps for motorized chairs); weighted eating utensils and dressing hooks to maintain independence; speech therapy and communication devices for those with dysarthria.</p><p><i>Prevention of secondary complications:</i> Dietary modifications when dysphagia becomes troublesome to reduce the risk for aspiration and maintain caloric intake.</p><p><i>Surveillance:</i> Annual evaluation of gait, coordination, and speech.</p><p><i>Agents/circumstances to avoid:</i> Obesity can exacerbate difficulties with ambulation and mobility.</p><p><i>Other:</i> Tremor-controlling drugs do not work well for cerebellar tremors.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SCA14 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Offspring of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual have a 50% chance of inheriting the <i>PRKCG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal testing is possible if the pathogenic variant in the family has been identified; however, requests for <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> of (typically) adult-onset diseases are not common.</p></div></div><div id="sca14.Diagnosis"><h2 id="_sca14_Diagnosis_">Diagnosis</h2><div id="sca14.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>No features of spinocerebellar ataxia type 14 (SCA14) are pathognomonic; therefore, diagnosis depends on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div id="sca14.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b> The only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause SCA14 is <i>PRKCG</i>, which encodes protein kinase C gamma type (PCK&#x003b3;) [<a class="bk_pop" href="#sca14.REF.chen.2003.839">Chen et al 2003</a>].</p><div id="sca14.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Spinocerebellar Ataxia Type 14</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1399/table/sca14.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca14.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKCG</i></td><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis of select exons</td><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4&#x000a0;<sup>6</sup></td><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>7</sup></td><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(Multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications</td><td headers="hd_h_sca14.T.molecular_genetic_testing_used_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sca14.TF.1.1"><p class="no_margin">See <a href="/books/NBK1399/#sca14.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sca14.TF.1.2"><p class="no_margin">See <a href="#sca14.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants</p></div></dd><dt>3. </dt><dd><div id="sca14.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="sca14.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="sca14.TF.1.5"><p class="no_margin">The prevalence of SCA14 and the full spectrum of pathogenic variants are unknown. To date, large-scale screening for pathogenic variants has been limited to methods that preferentially detect single-nucleotide variants and other small pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>. However, it is possible that <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> changes, duplications, and deletions that can only be identified using other test methods exist.</p></div></dd><dt>6. </dt><dd><div id="sca14.TF.1.6"><p class="no_margin">Exons may vary by laboratory; it is estimated that about 50% of pathogenic variants may be in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4.</p></div></dd><dt>7. </dt><dd><div id="sca14.TF.1.7"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>8. </dt><dd><div id="sca14.TF.1.8"><p class="no_margin">No deletions or duplications involving <i>PRKCG</i> as causative of SCA14 have been reported; diagnostic yield may be very low.</p></div></dd></dl></div></div></div></div><div id="sca14.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Establishing the diagnosis in a proband relies on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p></div></div><div id="sca14.Clinical_Characteristics"><h2 id="_sca14_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sca14.Clinical_Description"><h3>Clinical Description</h3><p>Clinical features of spinocerebellar ataxia type 14 (SCA14) are summarized in <a href="/books/NBK1399/bin/sca14-Table2.pdf">Table 2</a> (pdf). The initial finding is almost always subtle unsteadiness of gait that slowly worsens. Accurate age of onset is often difficult to determine. The usual onset is in early adult life, typically in the 30s (age range: 3-70 years) [<a class="bk_pop" href="#sca14.REF.yamashita.2000.156">Yamashita et al 2000</a>, <a class="bk_pop" href="#sca14.REF.brkanac.2002.1291">Brkanac et al 2002</a>, <a class="bk_pop" href="#sca14.REF.chen.2003.839">Chen et al 2003</a>, <a class="bk_pop" href="#sca14.REF.hiramoto.2006.1355">Hiramoto et al 2006</a>, <a class="bk_pop" href="#sca14.REF.vlak.2006.1025">Vlak et al 2006</a>].</p><p>Mild to moderate dysarthria is common. Findings seen in other ataxia disorders (e.g., dysphagia, dysphonia) may also occur in SCA14.</p><p>More than half of individuals have horizontal jerk nystagmus or saccadic intrusions.</p><p>One third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families show mild or moderate sensory loss, mostly decreased vibration sense.</p><p>Tendon reflexes vary from decreased to normal to hyperactive. Extensor plantar reflexes are present in a few cases.</p><p>Five persons in a Japanese family with early onset had episodic axial myoclonus manifest as irregular tremulous movements of the trunk and head lasting minutes to hours [<a class="bk_pop" href="#sca14.REF.yamashita.2000.156">Yamashita et al 2000</a>]. Although this feature has not been observed in most families with SCA14, mild persistent multifocal myoclonus has been reported in a person with early onset [<a class="bk_pop" href="#sca14.REF.vlak.2006.1025">Vlak et al 2006</a>] and a few other cases [<a class="bk_pop" href="#sca14.REF.van_de_warrenburg.2003.1760">van de Warrenburg et al 2003</a>, <a class="bk_pop" href="#sca14.REF.klebe.2005.720">Klebe et al 2005</a>, <a class="bk_pop" href="#sca14.REF.foncke.2010.288">Foncke et al 2010</a>]. An individual <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that results in extension of the protein by 13 amino acids had early onset and developed generalized myoclonus in late teenage years [<a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a>]. Identification of <i>PRKCG</i> pathogenic variants in persons with phenotypes similar to progressive myoclonic ataxia (Ramsay Hunt syndrome) [<a class="bk_pop" href="#sca14.REF.visser.2007.1024">Visser et al 2007</a>] and myoclonus-dystonia [<a class="bk_pop" href="#sca14.REF.foncke.2010.288">Foncke et al 2010</a>] suggest that SCA14 should be considered in individuals with these clinical syndromes.</p><p><a class="bk_pop" href="#sca14.REF.stevanin.2004.1242">Stevanin et al [2004]</a> reported facial fasciculations and/or myokymia in several individuals in one family.</p><p>Parkinsonian features including rigidity and tremor were described in some families [<a class="bk_pop" href="#sca14.REF.stevanin.2004.1242">Stevanin et al 2004</a>, <a class="bk_pop" href="#sca14.REF.van_de_warrenburg.2004.257">van de Warrenburg et al 2004</a>, <a class="bk_pop" href="#sca14.REF.fahey.2005.1720">Fahey et al 2005</a>, <a class="bk_pop" href="#sca14.REF.klebe.2005.720">Klebe et al 2005</a>, <a class="bk_pop" href="#sca14.REF.dalski.2006.1111">Dalski et al 2006</a>, <a class="bk_pop" href="#sca14.REF.vlak.2006.1025">Vlak et al 2006</a>, <a class="bk_pop" href="#sca14.REF.nolte.2007.265">Nolte et al 2007</a>, <a class="bk_pop" href="#sca14.REF.visser.2007.1024">Visser et al 2007</a>, <a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a> ].</p><p>Other extrapyramidal findings such as dystonia have also been reported [<a class="bk_pop" href="#sca14.REF.nolte.2007.265">Nolte et al 2007</a>, <a class="bk_pop" href="#sca14.REF.visser.2007.1024">Visser et al 2007</a>, <a class="bk_pop" href="#sca14.REF.miura.2009.211">Miura et al 2009</a>, <a class="bk_pop" href="#sca14.REF.foncke.2010.288">Foncke et al 2010</a>].</p><p>Cognitive deficits may be part of the SCA14 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#sca14.REF.stevanin.2004.1242">Stevanin et al 2004</a>]. Intellectual impairment, attention deficit, and deficient executive function were identified in 13 of 18 (72%) individuals in a French family [<a class="bk_pop" href="#sca14.REF.stevanin.2004.1242">Stevanin et al 2004</a>] and in a few families in another French study [<a class="bk_pop" href="#sca14.REF.klebe.2005.720">Klebe et al 2005</a>]. Two studies in Japanese families found severe intellectual disability in one individual with early onset [<a class="bk_pop" href="#sca14.REF.hiramoto.2006.1355">Hiramoto et al 2006</a>] and mild cognitive deficits in two members with adult-onset disease from another family [<a class="bk_pop" href="#sca14.REF.miura.2009.211">Miura et al 2009</a>]. Three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in a Norwegian family were described to have learning difficulty with IQ in the normal to low range [<a class="bk_pop" href="#sca14.REF.koht.2012.116">Koht et al 2012</a>].</p><p>Memory loss after age 70 years observed in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may be coincidentally occurring age-related dementia [<a class="bk_pop" href="#sca14.REF.chen.2005.1258">Chen et al 2005</a>]. Depression found in some families with SCA14 [<a class="bk_pop" href="#sca14.REF.chen.2003.839">Chen et al 2003</a>, <a class="bk_pop" href="#sca14.REF.chen.2005.1258">Chen et al 2005</a>, <a class="bk_pop" href="#sca14.REF.nolte.2007.265">Nolte et al 2007</a>, <a class="bk_pop" href="#sca14.REF.wieczorek.2007.2135">Wieczorek et al 2007</a>, <a class="bk_pop" href="#sca14.REF.miura.2009.211">Miura et al 2009</a>] may reflect general dysfunction in progressive diseases, rather than a feature specific to SCA14.</p><p>Hearing impairment was observed in two persons with SCA14 [<a class="bk_pop" href="#sca14.REF.stevanin.2004.1242">Stevanin et al 2004</a>, <a class="bk_pop" href="#sca14.REF.klebe.2005.720">Klebe et al 2005</a>], but it is not clear if the impairment results from <i>PRKCG</i> pathogenic variants.</p><p>One person with intractable epilepsy was reported in a Japanese family [<a class="bk_pop" href="#sca14.REF.hiramoto.2006.1355">Hiramoto et al 2006</a>].</p><p>Almost all persons remain ambulatory, but many fall frequently and require the assistance of stair railings and canes. Some people require a wheelchair late in life. Life span is not shortened and many persons live beyond age 70 years.</p><p><b>Neuroimaging.</b> Brain MRI in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons has shown mild to moderately severe cerebellar atrophy that is primarily midline. Atrophy of the brain stem or cerebral cortex is not observed.</p></div><div id="sca14.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Because all reported features have not been assessed in detail in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, evidence is currently insufficient to establish a specific correlation between genotypes and phenotypes.</p><p>Some individuals with SCA14, particularly those with younger age of onset, exhibit axial myoclonus [<a class="bk_pop" href="#sca14.REF.yamashita.2000.156">Yamashita et al 2000</a>, <a class="bk_pop" href="#sca14.REF.yabe.2003.1749">Yabe et al 2003</a>, <a class="bk_pop" href="#sca14.REF.klebe.2005.720">Klebe et al 2005</a>], multifocal myoclonus [<a class="bk_pop" href="#sca14.REF.vlak.2006.1025">Vlak et al 2006</a>, <a class="bk_pop" href="#sca14.REF.visser.2007.1024">Visser et al 2007</a>, <a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a>], or myokymia [<a class="bk_pop" href="#sca14.REF.stevanin.2004.1242">Stevanin et al 2004</a>]. However, the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in these families is not identical and the <i>PRKCG</i> pathogenic variants involved do not cluster in one region.</p><p>Cognitive deficits have been reported in a French family with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 18 affecting the C4 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#sca14.REF.stevanin.2004.1242">Stevanin et al 2004</a>] and in several French and Japanese families with different pathogenic variants in exon 4 affecting the C1 domain. In the American families with pathogenic variants in other <i>PRKCG</i> regions, two persons have had normal neuropsychological testing and two have developed dementia in older age [<a class="bk_pop" href="#sca14.REF.chen.2005.1258">Chen et al 2005</a>]; however, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons have not had detailed cognitive testing. The true prevalence of this problem in SCA14 is yet to be determined.</p><p>For the most part, pathogenic variants have been described in single families only, although compiled results of clinical testing have not been made public.</p><p>Pathogenic variants that have occurred in more than one family include p.His101Tyr [<a class="bk_pop" href="#sca14.REF.chen.2003.839">Chen et al 2003</a>, <a class="bk_pop" href="#sca14.REF.nolte.2007.265">Nolte et al 2007</a>], the founder p.Gly118Asp variant in the Dutch population [<a class="bk_pop" href="#sca14.REF.van_de_warrenburg.2003.1760">van de Warrenburg et al 2003</a>, <a class="bk_pop" href="#sca14.REF.verbeek.2005b.88">Verbeek et al 2005b</a>, <a class="bk_pop" href="#sca14.REF.visser.2007.1024">Visser et al 2007</a>], p.Phe643Leu in two French families, and p.Gly128Asp [<a class="bk_pop" href="#sca14.REF.chen.2003.839">Chen et al 2003</a>, <a class="bk_pop" href="#sca14.REF.morita.2006.1118">Morita et al 2006</a>, <a class="bk_pop" href="#sca14.REF.miura.2009.211">Miura et al 2009</a>]. Features such as myoclonus, cognitive deficits, tremor, and dystonia can differ between families that have the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p>Similarly, different pathogenic variants affecting the same residues (i.e., p.His101Tyr, p.His101Gln, and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> p.Lys100His101del; p.Ser119Pro and p.Ser119Phe; p.Gly123Arg and p.Gly123Glu; and p.Cys131Arg and p.Cys131Tyr) may produce different extracerebellar symptoms (see Table 2).</p></div><div id="sca14.Penetrance"><h3>Penetrance</h3><p>Too few families have been studied to specify the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> or to determine if decreased penetrance is related to specific pathogenic variants. However, clinically unaffected individuals with <i>PRKCG</i> pathogenic variants who are older than age 60 years have been described in at least two families [<a class="bk_pop" href="#sca14.REF.yabe.2003.1749">Yabe et al 2003</a>, <a class="bk_pop" href="#sca14.REF.chen.2005.1258">Chen et al 2005</a>]. In general, penetrance is high when late-onset cases are included [<a class="bk_pop" href="#sca14.REF.klebe.2005.720">Klebe et al 2005</a>].</p></div><div id="sca14.Anticipation"><h3>Anticipation</h3><p>SCA14 is not caused by an expansion of a <a class="def" href="/books/n/gene/glossary/def-item/nucleotide-repeat/">nucleotide repeat</a>. Earlier onset of disease in later generations suggestive of <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> [<a class="bk_pop" href="#sca14.REF.brkanac.2002.1291">Brkanac et al 2002</a>, <a class="bk_pop" href="#sca14.REF.van_de_warrenburg.2004.257">van de Warrenburg et al 2004</a>] most likely reflects either heightened awareness in families known to have ataxia or stochastic influences that contribute to the extreme variation in age of onset.</p></div><div id="sca14.Nomenclature"><h3>Nomenclature</h3><p>The term olivopontocerebellar atrophy (OPCA) was used to denote SCA in the past. Prior to the discovery of the genes that differentiate members of the group, the <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> cerebellar ataxias (ADCA) were divided into subgroups depending on the presence of clinical features in addition to ataxia. ADCA III, to which SCA14 would belong, referred to a pure form of late-onset cerebellar ataxia without additional features.</p></div><div id="sca14.Prevalence"><h3>Prevalence</h3><p>SCA14 probably accounts for fewer than 1% of unselected cases of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> ataxia. With the exception of the index family in which linkage to the SCA14 <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> was first demonstrated, no other <i>PRKCG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in 113 individuals of Japanese heritage with autosomal dominant SCA [<a class="bk_pop" href="#sca14.REF.basri.2007.848">Basri et al 2007</a>].</p><p>In two studies involving a total of 310 individuals with ataxia not caused by expansions in the genes for SCA1, 2, 3, 6, 7, and 8, four <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and two <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., individuals with no family history of ataxia) were found to have pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants or deletions in <i>PRKCG</i> [<a class="bk_pop" href="#sca14.REF.chen.2005.1258">Chen et al 2005</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> (p.Gly118Asp) has been reported in the Dutch population [<a class="bk_pop" href="#sca14.REF.verbeek.2005b.88">Verbeek et al 2005b</a>].</p></div></div><div id="sca14.Genetically_Related_Allelic_Disord"><h2 id="_sca14_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No known disorders are allelic to SCA14. However, a single <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 18 of <i>PRKCG</i> (p.Arg659Ser) was reported in four unrelated individuals with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a href="/books/n/gene/rp-overview/">retinitis pigmentosa</a> (RP) [<a class="bk_pop" href="#sca14.REF.almaghtheh.1998.1248">Al-Maghtheh et al 1998</a>]. Later studies identified <i>PRP31</i> (rather than <i>PRKCG</i>) as the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> associated with RP11 [<a class="bk_pop" href="#sca14.REF.vithana.2001.375">Vithana et al 2001</a>].</p></div><div id="sca14.Differential_Diagnosis"><h2 id="_sca14_Differential_Diagnosis_">Differential Diagnosis</h2><p>Persons with spinocerebellar ataxia type 14 (SCA14) may present with ataxia that is indistinguishable from other adult-onset inherited or acquired ataxias (see <a href="/books/n/gene/ataxias/">Ataxia Overview</a>). SCA14 should particularly be considered if the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> or an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative displays axial myoclonus or cognitive impairment.</p><p>SCA14 may mimic other disorders that are characterized by myoclonus including <a href="/books/n/gene/me-ataxia/">progressive myoclonus epilepsy with ataxia</a> caused by pathogenic variants in <i>PRICKLE1</i> [<a class="bk_pop" href="#sca14.REF.bassuk.2008.572">Bassuk et al 2008</a>] and <a href="/books/n/gene/myo-dystonia/">myoclonus-dystonia</a> caused by pathogenic variants in <i>SGCE</i> (formerly <i>DYT11</i>) [<a class="bk_pop" href="#sca14.REF.foncke.2010.288">Foncke et al 2010</a>]. Conversely, these other diagnoses can be considered if a diagnosis of SCA14 is entertained because of the presence of myoclonus, but a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not detected in <i>PRKCG</i>.</p><p>In the absence of linkage assignment to a specific SCA <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>, the most pragmatic and cost-effective testing strategy is to test first for pathogenic variants in the genes causing the more prevalent <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> SCAs (i.e., <a href="/books/n/gene/sca1/">SCA1</a>, <a href="/books/n/gene/sca2/">2</a>, <a href="/books/n/gene/sca3/">3</a>, <a href="/books/n/gene/sca6/">6</a>, <a href="/books/n/gene/sca7/">7</a>, and <a href="/books/n/gene/sca8/">8</a>) and if none are found, to proceed with testing for a <i>PRKCG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="sca14.Management"><h2 id="_sca14_Management_">Management</h2><div id="sca14.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with spinocerebellar ataxia type 14 (SCA14), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Medical history</div></li><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Brain MRI</div></li><li class="half_rhythm"><div>Clinical genetics consultation</div></li></ul></div><div id="sca14.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Axial myoclonus may be improved by clonazepam or valproic acid [<a class="bk_pop" href="#sca14.REF.yamashita.2000.156">Yamashita et al 2000</a>].</p><p>Although neither exercise nor physical therapy has been shown to stem the progression of incoordination or muscle weakness, individuals should continue to be active.</p><p>Canes and walkers help prevent falls. Modification of the home with such conveniences as grab bars, raised toilet seats, and ramps to accommodate motorized chairs may be necessary. Weighted eating utensils and dressing hooks help maintain a sense of independence.</p><p>Speech therapy and communication devices such as writing pads and computer-based devices may benefit those with dysarthria.</p><p>When dysphagia becomes troublesome, video esophagram can identify the consistency of food least likely to trigger aspiration.</p></div><div id="sca14.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>No dietary factor has been shown to curtail symptoms; however, vitamin supplements are recommended, particularly if caloric intake is reduced.</p><p>Weight control is important because obesity can exacerbate difficulties with ambulation and mobility.</p></div><div id="sca14.Surveillance"><h3>Surveillance</h3><p>Gait, coordination, and speech should be evaluated annually.</p></div><div id="sca14.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Alcohol and sedation may make gait and coordination worse.</p></div><div id="sca14.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sca14.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sca14.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="sca14.Other"><h3>Other</h3><p>Tremor-controlling drugs do not work well for cerebellar tremors.</p></div></div><div id="sca14.Genetic_Counseling"><h2 id="_sca14_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sca14.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Spinocerebellar ataxia type 14 (SCA14) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="sca14.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Many individuals diagnosed with SCA14 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>As most <i>PRKCG</i> pathogenic variants reported to date are <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a>, occurring in only a single family, it is clear that <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants may arise in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Too few unselected cases have been studied to derive a reliable estimate of the proportion of cases that result from a <i>de novo</i> variant, and in none of the apparently <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases have both parents been available for evaluation.</div></li><li class="half_rhythm"><div>It is recommended that both parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> be evaluated using <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li></ul><p>Note: Although most individuals diagnosed with SCA14 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, late onset of the disease in the affected parent, or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected and a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the DNA of either parent, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is probably low; however, very few cases have been studied to date. Although no instances of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported, it remains a possibility.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with SCA14 has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents. If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="sca14.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> variant. Possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or undisclosed adoption or maternity (e.g., with assisted reproduction) could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sca14.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>PRKCG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for SCA14 are possible.</p><p>Given that almost no reported <i>PRKCG</i> variants have been associated with functional evidence for pathogenicity, and that a rare benign <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> cannot be ruled out, results from <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> should be used with extreme caution for <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> at the present time.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="sca14.Resources"><h2 id="_sca14_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Ataxia UK</b></div><div>Lincoln House</div><div>1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> 0845 644 0606 (helpline); 020 7582 1444 (office); +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> helpline@ataxia.org.uk; office@ataxia.org.uk</div><div><a href="http://www.ataxia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org.uk</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>Spanish Ataxia Federation (FEDAES)</b></div><div>Spain</div><div><b>Phone:</b> 34 983 278 029; 34 985 097 152; 34 634 597 503</div><div><b>Email:</b> sede.valladolid@fedaes.org; sede.gijon@fedaes.org; sede.bilbao@fedaes.org</div><div><a href="http://www.fedaes.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fedaes.org</a></div></li><li class="half_rhythm"><div><b>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</b></div><div><i>Booklet providing information about Spinocerebellar Ataxia</i></div><div><a href="http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf</a></div></li><li class="half_rhythm"><div><b>CoRDS Registry</b></div><div>Sanford Research</div><div>2301 East 60th Street North</div><div>Sioux Falls SD 57104</div><div><b>Phone:</b> 605-312-6423</div><div><b>Email:</b> sanfordresearch@sanfordhealth.org</div><div><a href="http://www.sanfordresearch.org/SpecialPrograms/cords/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CoRDS Registry</a></div></li></ul></div><div id="sca14.Molecular_Genetics"><h2 id="_sca14_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sca14.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spinocerebellar Ataxia Type 14: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1399/table/sca14.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca14.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sca14.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sca14.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sca14.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sca14.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sca14.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sca14.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5582" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PRKCG</i></a></td><td headers="hd_b_sca14.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5582" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19q13<wbr style="display:inline-block"></wbr>​.42</a></td><td headers="hd_b_sca14.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P05129" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Protein kinase C gamma type</a></td><td headers="hd_b_sca14.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PRKCG" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRKCG</a></td><td headers="hd_b_sca14.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PRKCG[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRKCG</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sca14.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sca14.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spinocerebellar Ataxia Type 14 (<a href="/omim/176980,605361" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1399/table/sca14.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca14.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/176980" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">176980</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROTEIN KINASE C, GAMMA; PRKCG</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605361" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605361</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINOCEREBELLAR ATAXIA 14; SCA14</td></tr></tbody></table></div></div><div id="sca14.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Mutated PKC&#x003b3; aggregates in the cytoplasm of cultured cells transfected with mutated PKC&#x003b3; expression vectors [<a class="bk_pop" href="#sca14.REF.lin.2007.982">Lin &#x00026; Takemoto 2007</a>, <a class="bk_pop" href="#sca14.REF.seki.2007.3126">Seki et al 2007</a>, <a class="bk_pop" href="#sca14.REF.doran.2008.447">Doran et al 2008</a>], but the role of these aggregates in the pathogenesis of SCA14 is not known. When treated with an inducer of autophagy, cultured SH-SY5Y cells transfected with mutated PKC&#x003b3; demonstrated accelerated clearance of aggregates, indicating that autophagy contributes to the degradation of mutated PKC&#x003b3; [<a class="bk_pop" href="#sca14.REF.yamamoto.2010.425">Yamamoto et al 2010</a>]. In primary cultures of Purkinje cells transfected with mutated PKC&#x003b3;, abnormal dendritic development occurred independent of aggregation [<a class="bk_pop" href="#sca14.REF.seki.2009.260">Seki et al 2009</a>], <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> of mutated PKC&#x003b3; in PC dendrites was prominently reduced, and both pruning of climbing fiber synapses from developing PCs and long-term depression expression were impaired [<a class="bk_pop" href="#sca14.REF.seki.2011.239">Seki et al 2011</a>, <a class="bk_pop" href="#sca14.REF.shuvaev.2011.14324">Shuvaev et al 2011</a>].</p><p>PKC&#x003b3; is a serine-threonine kinase. Studies of the effect of SCA14-related pathogenic variants on kinase activity have not been consistent across groups, but a dominant negative effect has not been documented [<a class="bk_pop" href="#sca14.REF.seki.2005.29096">Seki et al 2005</a>, <a class="bk_pop" href="#sca14.REF.verbeek.2005a.436">Verbeek et al 2005a</a>, <a class="bk_pop" href="#sca14.REF.lin.2007.113">Lin et al 2007</a>, <a class="bk_pop" href="#sca14.REF.seki.2007.3126">Seki et al 2007</a>, <a class="bk_pop" href="#sca14.REF.verbeek.2008.2339">Verbeek et al 2008</a>, <a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a>].</p><p>Aprataxin (<i>APTX</i>), the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> associated with <a href="/books/n/gene/aoa/">autosomal recessive ataxia with oculomotor apraxia type 1</a> (AOA1) [<a class="bk_pop" href="#sca14.REF.moreira.2001.189">Moreira et al 2001</a>], was found to be a preferential substrate of mutated PKC&#x003b3; [<a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a>]. This observation suggests that the pathogenesis of SCA14 may involve altered phosphorylation-dependent pathways.</p><p>Cells expressing mutated PKC&#x003b3; exhibit increased oxidative stress-induced DNA damage and cell death [<a class="bk_pop" href="#sca14.REF.seki.2007.3126">Seki et al 2007</a>, <a class="bk_pop" href="#sca14.REF.doran.2008.447">Doran et al 2008</a>, <a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a>]. The ubiquitin-proteasome pathway has been implicated in this process [<a class="bk_pop" href="#sca14.REF.seki.2007.3126">Seki et al 2007</a>].</p><p>The observation that mutated PKC&#x003b3; fails to phosphorylate TRPC channels, resulting in sustained Ca<sup>2+</sup> entry into the cell, supports a role for abnormal Ca<sup>2+</sup>-mediated signaling in neurodegeneration [<a class="bk_pop" href="#sca14.REF.adachi.2008.19854">Adachi et al 2008</a>].</p><p>A transgenic mouse model with ubiquitous expression of human mutated <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> p.His101Tyr-PKC&#x003b3; manifests loss of Purkinje cells at age four weeks and stereotypic clasping responses in the hind limbs [<a class="bk_pop" href="#sca14.REF.zhang.2009.524">Zhang et al 2009</a>].</p><p><b>Gene structure.</b>
<i>PRKCG</i> has 18 exons encompassing 25 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA.</p><p><b>Benign variants.</b> Multiple silent variants have been identified.</p><p>The variant c.285C&#x0003e;T was reported as a possible <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant [<a class="bk_pop" href="#sca14.REF.chen.2005.1258">Chen et al 2005</a>], but later was found to be a <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> in individuals of North African descent [<a class="bk_pop" href="#sca14.REF.klebe.2005.720">Klebe et al 2005</a>].</p><p>Note: A nucleotide change resulting in an amino acid substitution (p.Arg659Ser) reported in families with RP11 [<a class="bk_pop" href="#sca14.REF.almaghtheh.1998.1248">Al-Maghtheh et al 1998</a>] is likely a <a class="def" href="/books/n/gene/glossary/def-item/benign-variant/">benign variant</a> because a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in another <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (<i>PRPF31</i>) was later found to be causative in these families [<a class="bk_pop" href="#sca14.REF.vithana.2001.375">Vithana et al 2001</a>].</p><p><b>Pathogenic variants.</b> Twenty-three pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, one <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, and a 102-bp deletion from the last coding nucleotide (codon 697) have been described (Table 2). The majority of pathogenic variants in <i>PRKCG</i> described to date are in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 (13/25, or 52%); this exon appears to be a relative mutational <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> (for more information, see Table 2). Other reported pathogenic variants are located in exons 1, 2, 3, 5, 7, 10, and 18.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The 3-kb <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> encodes 697 amino acids. PKC is a multifunctional family of closely related serine/threonine protein kinases that function in a wide variety of cellular processes, such as membrane-receptor signal transduction and control of gene expression [<a class="bk_pop" href="#sca14.REF.zeidman.1999.494">Zeidman et al 1999</a>, <a class="bk_pop" href="#sca14.REF.newton.2001.2353">Newton 2001</a>]. They are organized into three subgroups on the basis of diacylglycerol/phorbol ester binding and Ca<sup>++</sup> dependence [<a class="bk_pop" href="#sca14.REF.nishizuka.2001.3s">Nishizuka 2001</a>, <a class="bk_pop" href="#sca14.REF.amadio.2006.317">Amadio et al 2006</a>]. PKC&#x003b3; is a member of the conventional or typical subgroup because it is calcium activated and phospholipid dependent. It comprises [<a class="bk_pop" href="#sca14.REF.newton.2001.2353">Newton 2001</a>]:</p><ul><li class="half_rhythm"><div>An amino-terminal regulatory <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> containing a calcium-binding region and two cysteine-rich regions; and</div></li><li class="half_rhythm"><div>A carboxyl-terminal catalytic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> containing ATP-binding and substrate recognition sites.</div></li></ul><p>PKC&#x003b3; is highly expressed in brain and spinal cord, with particularly high expression in Purkinje cells of the cerebellar cortex during dendritic development. It is thought to be a negative regulator of dendritic growth and branching [<a class="bk_pop" href="#sca14.REF.schrenk.2002.675">Schrenk et al 2002</a>]. PKC&#x003b3; also localizes in lens epithelial cells and the hippocampus and amygdala, regions of the brain associated with anxiety and memory.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The pathogenic variants identified to date result in amino acid substitutions, <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of two residues, or deletion involving the termination codon that results in extension of the protein by 13 amino acids. <i>In silico</i> and in vitro investigations of some effects of these pathogenic variants on the function of the protein have been performed. Computer simulation studies on three pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants [<a class="bk_pop" href="#sca14.REF.chen.2003.839">Chen et al 2003</a>] suggested that mutated gene products may be less stable than the normal protein. In vitro experiments on multiple pathogenic missense variants demonstrated protein aggregation [<a class="bk_pop" href="#sca14.REF.lin.2007.982">Lin &#x00026; Takemoto 2007</a>, <a class="bk_pop" href="#sca14.REF.seki.2007.3126">Seki et al 2007</a>, <a class="bk_pop" href="#sca14.REF.doran.2008.447">Doran et al 2008</a>], altered kinase activity [<a class="bk_pop" href="#sca14.REF.seki.2005.29096">Seki et al 2005</a>, <a class="bk_pop" href="#sca14.REF.verbeek.2005a.436">Verbeek et al 2005a</a>, <a class="bk_pop" href="#sca14.REF.lin.2007.113">Lin et al 2007</a>, <a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a>], and altered substrate specificity [<a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a>]. It is speculated that the SCA14 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> results from gain of function rather than <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> because no chain-terminating pathogenic variants have been found, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> PKC&#x003b3;-<a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> animals are neurologically normal, and mutated PKC&#x003b3; showed a different substrate preference from wild type [<a class="bk_pop" href="#sca14.REF.asai.2009.3533">Asai et al 2009</a>].</p></div></div><div id="sca14.References"><h2 id="_sca14_References_">References</h2><div id="sca14.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.adachi.2008.19854">Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N. Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis. <span><span class="ref-journal">J Biol Chem. </span>2008;<span class="ref-vol">283</span>:19854–63.</span> [<a href="/pubmed/18499672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18499672</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.almaghtheh.1998.1248">Al-Maghtheh M, Vithana EN, Inglehearn CF, Moore T, Bird AC, Bhattacharya SS. Segregation of a PRKCG mutation in two RP11 families. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">62</span>:1248–52.</span> [<a href="/pmc/articles/PMC1377077/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377077</span></a>] [<a href="/pubmed/9545390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9545390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.amadio.2006.317">Amadio M, Battaini F, Pascale A. The different facets of protein kinases C: old and new players in neuronal signal transduction pathways. <span><span class="ref-journal">Pharmacol Res. </span>2006;<span class="ref-vol">54</span>:317–25.</span> [<a href="/pubmed/16996748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16996748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.asai.2009.3533">Asai H, Hirano M, Shimada K, Kiriyama T, Furiya Y, Ikeda M, Iwamoto T, Mori T, Nishinaka K, Konishi N, Udaka F, Ueno S. Protein kinase C gamma, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxin. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:3533–43.</span> [<a href="/pubmed/19561170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19561170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.basri.2007.848">Basri R, Yabe I, Soma H, Sasaki H. Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families. <span><span class="ref-journal">J Hum Genet. </span>2007;<span class="ref-vol">52</span>:848–55.</span> [<a href="/pubmed/17805477" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17805477</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.bassuk.2008.572">Bassuk AG, Wallace RH, Buhr A, Buller AR, Afawi Z, Shimojo M, Miyata S, Chen S, Gonzalez-Alegre P, Griesbach HL, Wu S, Nashelsky M, Vladar EK, Antic D, Ferguson PJ, Cirak S, Voit T, Scott MP, Axelrod JD, Gurnett C, Daoud AS, Kivity S, Neufeld MY, Mazarib A, Straussberg R, Walid S, Korczyn AD, Slusarski DC, Berkovic SF, El-Shanti HI. A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">83</span>:572–81.</span> [<a href="/pmc/articles/PMC2668041/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2668041</span></a>] [<a href="/pubmed/18976727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18976727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.brkanac.2002.1291">Brkanac Z, Bylenok L, Fernandez M, Matsushita M, Lipe H, Wolff J, Nochlin D, Raskind WH, Bird TD. A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. <span><span class="ref-journal">Arch Neurol. </span>2002;<span class="ref-vol">59</span>:1291–5.</span> [<a href="/pubmed/12164726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12164726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.chen.2003.839">Chen DH, Brkanac Z, Verlinde CL, Tan XJ, Bylenok L, Nochlin D, Matsushita M, Lipe H, Wolff J, Fernandez M, Cimino PJ, Bird TD, Raskind WH. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:839–49.</span> [<a href="/pmc/articles/PMC1180348/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180348</span></a>] [<a href="/pubmed/12644968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12644968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.chen.2005.1258">Chen DH, Cimino PJ, Ranum LP, Zoghbi HY, Yabe I, Schut L, Margolis RL, Lipe HP, Feleke A, Matsushita M, Wolff J, Morgan C, Lau D, Fernandez M, Sasaki H, Raskind WH, Bird TD. The clinical and genetic spectrum of spinocerebellar ataxia 14. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1258–60.</span> [<a href="/pubmed/15824357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15824357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.dalski.2006.1111">Dalski A, Mitulla B, Burk K, Schattenfroh C, Schwinger E, Zuhlke C. Mutation of the highly conserved cysteine residue 131 of the SCA14 associated PRKCG gene in a family with slow progressive cerebellar ataxia. <span><span class="ref-journal">J Neurol. </span>2006;<span class="ref-vol">253</span>:1111–2.</span> [<a href="/pubmed/16649092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16649092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.doran.2008.447">Doran G, Davies KE, Talbot K. Activation of mutant protein kinase Cgamma leads to aberrant sequestration and impairment of its cellular function. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2008;<span class="ref-vol">372</span>:447–53.</span> [<a href="/pubmed/18503760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18503760</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.fahey.2005.1720">Fahey MC, Knight MA, Shaw JH, Gardner RJ, du Sart D, Lockhart PJ, Delatycki MB, Gates PC, Storey E. Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2005;<span class="ref-vol">76</span>:1720–2.</span> [<a href="/pmc/articles/PMC1739431/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1739431</span></a>] [<a href="/pubmed/16291902" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16291902</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.foncke.2010.288">Foncke EM, Beukers RJ, Tijssen CC, Koelman JH, Tijssen MA. Myoclonus-dystonia and spinocerebellar ataxia type 14 presenting with similar phenotypes: trunk tremor, myoclonus, and dystonia. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2010;<span class="ref-vol">16</span>:288–9.</span> [<a href="/pubmed/19913450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19913450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.hiramoto.2006.1355">Hiramoto K, Kawakami H, Inoue K, Seki T, Maruyama H, Morino H, Matsumoto M, Kurisu K, Sakai N. Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4. <span><span class="ref-journal">Mov Disord. </span>2006;<span class="ref-vol">21</span>:1355–60.</span> [<a href="/pubmed/16763984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16763984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.klebe.2005.720">Klebe S, Durr A, Rentschler A, Hahn-Barma V, Abele M, Bouslam N, Schols L, Jedynak P, Forlani S, Denis E, Dussert C, Agid Y, Bauer P, Globas C, Wullner U, Brice A, Riess O, Stevanin G. New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">58</span>:720–9.</span> [<a href="/pubmed/16193476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16193476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.koht.2012.116">Koht J., Stevanin G., Durr A., Mundwiller E., Brice A., Tallaksen C.M.E. SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene. <span><span class="ref-journal">Acta Neurologica Scandinavica. </span>2012;<span class="ref-vol">125</span>:116–22.</span> [<a href="/pubmed/21434874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21434874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.lin.2007.113">Lin D, Shanks D, Prakash O, Takemoto DJ. Protein kinase C gamma mutations in the C1B domain cause caspase-3-linked apoptosis in lens epithelial cells through gap junctions. <span><span class="ref-journal">Exp Eye Res. </span>2007;<span class="ref-vol">85</span>:113–22.</span> [<a href="/pmc/articles/PMC2030616/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2030616</span></a>] [<a href="/pubmed/17493614" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17493614</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.lin.2007.982">Lin D, Takemoto DJ. Protection from ataxia-linked apoptosis by gap junction inhibitors. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2007;<span class="ref-vol">362</span>:982–7.</span> [<a href="/pmc/articles/PMC2034346/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2034346</span></a>] [<a href="/pubmed/17822669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17822669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.miura.2009.211">Miura S, Nakagawara H, Kaida H, Sugita M, Noda K, Motomura K, Ohyagi Y, Ayabe M, Aizawa H, Ishibashi M, Taniwaki T. Expansion of the phenotypic spectrum of SCA14 caused by the Gly128Asp mutation in PRKCG. <span><span class="ref-journal">Clin Neurol Neurosurg. </span>2009 Feb;<span class="ref-vol">111</span>:211–5.</span> [<a href="/pubmed/18986758" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18986758</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.moreira.2001.189">Moreira MC, Barbot C, Tachi N, Kozuka N, Uchida E, Gibson T, Mendon&#x000e7;a P, Costa M, Barros J, Yanagisawa T, Watanabe M, Ikeda Y, Aoki M, Nagata T, Coutinho P, Sequeiros J, Koenig M. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:189–93.</span> [<a href="/pubmed/11586300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11586300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.morita.2006.1118">Morita H, Yoshida K, Suzuki K, Ikeda S. A Japanese case of SCA14 with the Gly128Asp mutation. <span><span class="ref-journal">J Hum Genet. </span>2006;<span class="ref-vol">51</span>:1118–21.</span> [<a href="/pubmed/17024314" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17024314</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.newton.2001.2353">Newton AC. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. <span><span class="ref-journal">Chem Rev. </span>2001;<span class="ref-vol">101</span>:2353–64.</span> [<a href="/pubmed/11749377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11749377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.nishizuka.2001.3s">Nishizuka Y. The protein kinase C family and lipid mediators for transmembrane signaling and cell regulation. <span><span class="ref-journal">Alcohol Clin Exp Res. </span>2001;<span class="ref-vol">25</span>:3S–7S.</span> [<a href="/pubmed/11391043" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11391043</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.nolte.2007.265">Nolte D, Landendinger M, Schmitt E, M&#x000fc;ller U. Spinocerebellar ataxia 14: novel mutation in exon 2 of PRKCG in a German family. <span><span class="ref-journal">Mov Disord. </span>2007;<span class="ref-vol">22</span>:265–7.</span> [<a href="/pubmed/17149711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17149711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.schrenk.2002.675">Schrenk K, Kapfhammer JP, Metzger F. Altered dendritic development of cerebellar Purkinje cells in slice cultures from protein kinase Cgamma-deficient mice. <span><span class="ref-journal">Neuroscience. </span>2002;<span class="ref-vol">110</span>:675–89.</span> [<a href="/pubmed/11934475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11934475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.seki.2005.29096">Seki T, Adachi N, Ono Y, Mochizuki H, Hiramoto K, Amano T, Matsubayashi H, Matsumoto M, Kawakami H, Saito N, Sakai N. Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol">280</span>:29096–106.</span> [<a href="/pubmed/15964845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15964845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.seki.2009.260">Seki T, Shimahara T, Yamamoto K, Abe N, Amano T, Adachi N, Takahashi H, Kashiwagi K, Saito N, Sakai N. Mutant gammaPKC found in spinocerebellar ataxia type 14 induces aggregate-independent maldevelopment of dendrites in primary cultured Purkinje cells. <span><span class="ref-journal">Neurobiol Dis. </span>2009;<span class="ref-vol">33</span>:260–73.</span> [<a href="/pubmed/19041943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19041943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.seki.2007.3126">Seki T, Takahashi H, Adachi N, Abe N, Shimahara T, Saito N, Sakai N. Aggregate formation of mutant protein kinase C gamma found in spinocerebellar ataxia type 14 impairs ubiquitin-proteasome system and induces endoplasmic reticulum stress. <span><span class="ref-journal">Eur J Neurosci. </span>2007;<span class="ref-vol">26</span>:3126–40.</span> [<a href="/pubmed/18005063" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18005063</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.seki.2011.239">Seki T, Adachi N, Abe-Seki N, Shimahara T, Takahashi H, Yamamoto K, Saito N, Sakai N. Elucidation of the molecular mechanism and exploration of novel therapeutics for spinocerebellar ataxia caused by mutant protein kinase C&#x003b3;. <span><span class="ref-journal">J Pharmacol Sci. </span>2011;<span class="ref-vol">116</span>:239–47.</span> [<a href="/pubmed/21666345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21666345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.shuvaev.2011.14324">Shuvaev AN, Horiuchi H, Seki T, Goenawan H, Irie T, Iizuka A, Sakai N, Hirai H. Mutant PKC&#x003b3; in spinocerebellar ataxia type 14 disrupts synapse elimination and long-term depression in Purkinje cells in vivo. <span><span class="ref-journal">J Neurosci. </span>2011;<span class="ref-vol">31</span>:14324–34.</span> [<a href="/pmc/articles/PMC6623654/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6623654</span></a>] [<a href="/pubmed/21976518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21976518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.stevanin.2004.1242">Stevanin G, Hahn V, Lohmann E, Bouslam N, Gouttard M, Soumphonphakdy C, Welter ML, Ollagnon-Roman E, Lemainque A, Ruberg M, Brice A, Durr A. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. <span><span class="ref-journal">Arch Neurol. </span>2004;<span class="ref-vol">61</span>:1242–8.</span> [<a href="/pubmed/15313841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15313841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.van_de_warrenburg.2004.257">van de Warrenburg BP, Notermans NC, Schelhaas HJ, van Alfen N, Sinke RJ, Knoers NV, Zwarts MJ, Kremer BP. Peripheral nerve involvement in spinocerebellar ataxias. <span><span class="ref-journal">Arch Neurol. </span>2004;<span class="ref-vol">61</span>:257–61.</span> [<a href="/pubmed/14967775" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14967775</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.van_de_warrenburg.2003.1760">van de Warrenburg BP, Verbeek DS, Piersma SJ, Hennekam FA, Pearson PL, Knoers NV, Kremer HP, Sinke RJ. Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:1760–5.</span> [<a href="/pubmed/14694043" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14694043</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.verbeek.2008.2339">Verbeek DS, Goedhart J, Bruinsma L, Sinke RJ, Reits EA. PKC gamma mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling. <span><span class="ref-journal">J Cell Sci. </span>2008;<span class="ref-vol">121</span>:2339–49.</span> [<a href="/pubmed/18577575" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18577575</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.verbeek.2005a.436">Verbeek DS, Knight MA, Harmison GG, Fischbeck KH, Howell BW. Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting. <span><span class="ref-journal">Brain. </span>2005a;<span class="ref-vol">128</span>:436–42.</span> [<a href="/pubmed/15618281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15618281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.verbeek.2005b.88">Verbeek DS, Warrenburg BP, Hennekam FA, Dooijes D, Ippel PF, Verschuuren-Bemelmans CC, Kremer HP, Sinke RJ. Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population. <span><span class="ref-journal">Hum Genet. </span>2005b;<span class="ref-vol">117</span>:88–91.</span> [<a href="/pubmed/15841389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15841389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.visser.2007.1024">Visser JE, Bloem BR, van de Warrenburg BP. PRKCG mutation (SCA-14) causing a Ramsay Hunt phenotype. <span><span class="ref-journal">Mov Disord. </span>2007;<span class="ref-vol">22</span>:1024–6.</span> [<a href="/pubmed/17343273" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17343273</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.vithana.2001.375">Vithana EN, Abu-Safieh L, Allen MJ, Carey A, Papaioannou M, Chakarova C, Al-Maghtheh M, Ebenezer ND, Willis C, Moore AT, Bird AC, Hunt DM, Bhattacharya SS. A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). <span><span class="ref-journal">Mol Cell. </span>2001;<span class="ref-vol">8</span>:375–81.</span> [<a href="/pubmed/11545739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11545739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.vlak.2006.1025">Vlak MH, Sinke RJ, Rabelink GM, Kremer BP, van de Warrenburg BP. Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. <span><span class="ref-journal">Mov Disord. </span>2006;<span class="ref-vol">21</span>:1025–8.</span> [<a href="/pubmed/16547918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16547918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.wieczorek.2007.2135">Wieczorek S, Arning L, Gizewski ER, Alheite I, Timmann D. Benign SCA14 phenotype in a German patient associated with a missense mutation in exon 3 of the PRKCG gene. <span><span class="ref-journal">Mov Disord. </span>2007;<span class="ref-vol">22</span>:2135–6.</span> [<a href="/pubmed/17708558" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17708558</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.yabe.2003.1749">Yabe I, Sasaki H, Chen DH, Raskind WH, Bird TD, Yamashita I, Tsuji S, Kikuchi S, Tashiro K. Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:1749–51.</span> [<a href="/pubmed/14676051" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14676051</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.yamamoto.2010.425">Yamamoto K, Seki T, Adachi N, Takahashi T, Tanaka S, Hide I, Saito N, Sakai N. Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy. <span><span class="ref-journal">Genes Cells. </span>2010;<span class="ref-vol">15</span>:425–38.</span> [<a href="/pubmed/20398063" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20398063</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.yamashita.2000.156">Yamashita I, Sasaki H, Yabe I, Fukazawa T, Nogoshi S, Komeichi K, Takada A, Shiraishi K, Takiyama Y, Nishizawa M, Kaneko J, Tanaka H, Tsuji S, Tashiro K. A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cM interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">48</span>:156–63.</span> [<a href="/pubmed/10939565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10939565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.zeidman.1999.494">Zeidman R, Pettersson L, Sailaja PR, Truedsson E, Fagerstrom S, Pahlman S, Larsson C. Novel and classical protein kinase C isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells. <span><span class="ref-journal">Int J Cancer. </span>1999;<span class="ref-vol">81</span>:494–501.</span> [<a href="/pubmed/10209967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10209967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca14.REF.zhang.2009.524">Zhang Y, Snider A, Willard L, Takemoto DJ, Lin D. Loss of Purkinje cells in the PKCgamma H101Y transgenic mouse. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2009;<span class="ref-vol">378</span>:524–8.</span> [<a href="/pmc/articles/PMC4079109/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4079109</span></a>] [<a href="/pubmed/19056342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19056342</span></a>]</div></li></ul></div></div><div id="sca14.Chapter_Notes"><h2 id="_sca14_Chapter_Notes_">Chapter Notes</h2><div id="sca14.Author_Notes"><h3>Author Notes</h3><p>Supported by funds from the NORD, the NINDS, and the Department of Veterans Affairs</p></div><div id="sca14.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>18 April 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 March 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 February 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 December 2005 (dhc) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available</div></li><li class="half_rhythm"><div>28 January 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>23 September 2004 (dhc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1399</span><span class="label">PMID: <a href="/pubmed/20301573" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301573</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca13/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca15/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1399&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1399/?report=reader">PubReader</a></li><li><a href="/books/NBK1399/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1399" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1399" style="display:none" title="Cite this Page"><div class="bk_tt">Chen DH, Bird TD, Raskind WH. Spinocerebellar Ataxia Type 14. 2005 Jan 28 [Updated 2013 Apr 18]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1399/pdf/Bookshelf_NBK1399.pdf">PDF version of this page</a> (190K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sca14.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sca14.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sca14.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sca14.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sca14.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sca14.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sca14.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sca14.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sca14.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sca14.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sca14.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5582[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRKCG</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1399+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1470680" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1470680" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1470680" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1470680" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301363" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Opal P, Ashizawa T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301445" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 8</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 8<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ayhan F, Ikeda Y, Dalton JC, Day JW, Ranum LPW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301452" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 2</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 2<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pulst SM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31294938" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 38</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 38<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brusco A, Di Gregorio E, Borroni B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301433" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 7</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 7<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Garden G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301573" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301573" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042a00dd21425a25a8b70e">Spinocerebellar Ataxia Type 14 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Spinocerebellar Ataxia Type 14 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:33:20-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8DDCBAE041F6510000000004BF01C4&amp;ncbi_session=CE8DDCBAE0429FF1_1215SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1399%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1399&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1399/&amp;ncbi_pagename=Spinocerebellar Ataxia Type 14 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8DDCBAE0429FF1_1215SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>